Vaccination appears to protect from Long COVID
DALL-E's illustration of how people enjoy robust health and vitality after getting vaccinated

Vaccination appears to protect from Long COVID

Recent data on long COVID (also known as post-acute COVID syndrome, PACS) published in the CDC's Morbidity Mortality Weekly Reports (MMWR) Feb 15, 2024 shows the state-by-state rates of Long COVID in the U.S. The data were collected via telephone interview of non-institutionalized US adults who self reported cases of COVID and persistent symptoms for ≥ 3 months following COVID infection.

These latest data show that the rates of Long COVID vary dramatically from state to state, with the lowest rates occurring in US Virgin Islands (1.9%), D.C. (3.5%), HI (3.8%), and Vermont (4.2%), and the highest rates occurring in WV (10.6%), Alabama (9.8%), Montana (9.8%), and North Dakota (9.3%).

Perhaps not surprisingly, the rates of Long COVID correlate with the rates of COVID vaccination – states with the highest rates of COVID vaccination have the lowest rates of Long COVID:

Figure 1. Comparison of state-wide rates of Long COVID and of adult immunization against COVID (1+ doses).

A criticism of the conclusion that COVID vaccination independently reduces the rate of Long COVID is that vaccinations may prevent Long COVID only because they prevent COVID illness in the first place.

A study published in Annals of Epidemiology this week provides compelling data that show that COVID vaccination independently protects against Long COVID. The study looked at vaccinated and unvaccinated Michiganders who got COVID and Long COVID.

The Long COVID prevalence was 40–60% lower among those who were vaccinated prior to getting COVID compared to the unvaccinated.

As the authors conclude: "These findings support the growing evidence that COVID-19 vaccination may be an important tool to reduce the burden of long COVID, providing evidence that can inform public health messaging..."

References

Cumulative Percentage of Adults 18 Years and Older Vaccinated with the Updated 2023-24 COVID-19 Vaccine (CDC)

Long COVID Prevalence Among Adults (MMWR)

The impact of COVID-19 vaccination prior to SARS-CoV-2 infection on prevalence of long COVID (Annals of Epidemiology)

Paul Keenan

Interim Head of Technical/Senior Technical Manager

7 个月

You might want to read this piece of research. Having attended Long COVID clinics I meet patients who never had COVID but developed long COVID after vaccination. It's important to note that I am not anti vaccine. It HAS saved lives. Unfortunately in every binomial distribution a smaller number has reacted negatively to vaccines. The spike protein in vaccines, although modified, can still unravel/cleaved into pathogenic peptides, like Sars spike protein, which the body can no longer eliminate. These can remain in cells blocking mitochondrial function and/or Co-Q10 levels. In the blood system they can build into an amyloid condition. It was reported before vaccination that micro-clot can form with vaccines and these can grow into more serious deep vein clots. According to which organs the spike protein has attached determines which symptoms may develop from the inflammation. Vaccines HAVE saved lives. However to roll out the vaccines quickly governments across the world had to accept liability for any negative implications. Therefore the Vaccination providers are no longer liable. Governments must step up and provide resources for long term care not short term funding https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663976/

回复

要查看或添加评论,请登录

社区洞察

其他会员也浏览了